If you think the emergence of GLP-1 therapies has been exciting, there is another hormone that I think deserves just as much attention as we look toward the future of obesity treatment. And that hormone is amylin. We’ve spent the last several years talking about semaglutide, tirzepatide, and the incredible changes we’ve seen with medications […]